Belgian Society of Medical Oncology (BSMO) posted on LinkedIn:
“Belgium is advancing precision oncology through national and regional tumor boards supported by the BSMO, with studies proving the value of broad genomic profiling. The first results of the BALLETT study were recently published. However, sustainable support and reimbursement for these efforts remain critical.”
Title: A nationwide comprehensive genomic profiling and molecular tumor board platform for patients with advanced cancer
Authors: Pieter-Jan Volders, Philippe Aftimos, Franceska Dedeurwaerdere, Geert Martens, Jean-Luc Canon, Gabriela Beniuga, Guy Froyen, Jacques Van Huysse, Rebecca De Pauw, Hans Prenen, Suzan Lambin, Lore Decoster, Freya Vaeyens, Sylvie Rottey, Pieter-Jan Van Dam, Lynn Decoster, Annemie Rutten, Max Schreuer, Siebe Loontiens, Joni Van der Meulen, Jeroen Mebis, Kristof Cuppens, Sabine Tejpar, Isabelle Vanden Bempt, Brigitte Maes
Read The Full Article at NPJ.
